Reviv3 Procare to acquire Axil & Associated Brands for ~$33M in stock, expanding into hearing protection

Axil Brands, Inc.

Purchase price of $33.3M via 73.2M common shares and 250M non-voting preferred shares convertible 1:1; 25.9% discount to 22-day VWAP.
Acquired assets include ear plugs, ear muffs, and ear buds; Axil retains its hearing aid line.
Closing requires shareholder approvals and a 5-to-1 reverse stock split within 90 days post-closing.
Preferred shares subject to 2-year lock-up; no conversion or transfer during that period, with 5% beneficial ownership cap thereafter.
Transaction approved by both boards; expected to close within 90 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.